PACS Expands Florida Footprint With 32-Facility Acquisition
PACS plans to acquire operations of 32 Florida skilled nursing facilities, adding 4,049 licensed beds and establishing a statewide network.
PACS - PACS Group, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$56.67
DETAILS
HIGH:
$62.00
LOW:
$48.00
MEDIAN:
$60.00
CONSENSUS:
$56.67
UPSIDE:
27.06%
Stock News
Bank of New York Mellon Corp Takes Position in PACS Group, Inc. $PACS
Bank of New York Mellon Corp bought a new stake in PACS Group, Inc. (NYSE: PACS) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 192,210 shares of the company's stock, valued at approximately $8,196,000. Bank of New York Mellon Corp
PACS Group: The Peer Check Stopped Me From Calling It Cheap
I rate PACS a Buy and value the shares at $49.58, about 17% above the August 31 closing price. Q2 revenue rose 9.1%, operating income grew 35.8%, and same-store occupancy reached 90.6%. Eduro adds 3,633 beds. My 2027 model includes $260 million of incremental revenue after a 27% haircut.
PACS Group to Acquire Operations of 32 Facilities Across Florida and Closes on Additional Previously Announced Eduro Facilities
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) announced today that subsidiaries of the Company have entered into definitive agreements to acquire the operations of 32 skilled nursing facilities across Florida. The facilities will be leased from subsidiaries of one of our existing REIT landlords, Omega Healthcare Investors, Inc. (NYSE: OHI).The facilities have a combined 4,049 licensed skilled nursing beds and are deeply integrated into local healthcare networks throughout Florid.
Allegion Redefines Commercial Access Control with the Schlage XE360™ Series featuring RealSync™ Persistent Wi-Fi Technology
Allegion Redefines Commercial Access Control with the Schlage XE360⢠Series featuring RealSync⢠Persistent Wi-Fi Technology P
Zacks Industry Outlook CareDx, BrightSpring and PACS
CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.
3 Medical Service Stocks Resilient Amid Persistent Workforce Shortage
CareDx, BrightSpring and PACS Group are positioned for growth as digital health expands and workforce shortages reshape medical services.
Amid Legal Risks, This Company Is Still Rated a Buy
When investors look for stocks riding the aging of America, they might look at hospital chains, pharmacy benefit managers, or dividend-paying healthcare REITs.
Wall Street Analysts See a 25.73% Upside in PACS Group, Inc. (PACS): Can the Stock Really Move This High?
The consensus price target hints at a 25.7% upside potential for PACS Group, Inc. (PACS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
PACS Group Q2 Earnings Call Highlights
PACS Group NYSE: PACS reported second-quarter 2026 revenue growth of 9.1% and adjusted EBITDA growth of 25% from a year earlier, citing higher occupancy, improved skilled nursing patient mix and continued progress across acquired facilities as they mature within its operating model.
PACS Group, Inc. (PACS) Q2 2026 Earnings Call Transcript
PACS Group, Inc. (PACS) Q2 2026 Earnings Call Transcript
PACS Group, Inc. (PACS) Surpasses Q2 Earnings and Revenue Estimates
PACS Group, Inc. (PACS) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.31 per share a year ago.
PACS Group, Inc. Reports Second Quarter 2026 Results
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the second quarter of 2026. Second Quarter 2026 Financial Highlights Revenue was $1.43 billion, an increase of 9.1% over prior year. Net income was $76.3 million, an increase of $25.4 million, or 49.8% from $51.0 million in the prior-year period. Diluted Earnings.
PACS or ALHC: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with PACS Group, Inc. (PACS) and Alignment Healthcare (ALHC). But which of these two companies is the best option for those looking for undervalued stocks?
PACS Group Schedules Second Quarter 2026 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that it intends to report its financial results for the second quarter ended June 30, 2026, on Tuesday, August 4, 2026, after the stock market closes. Management will host a call on Wednesday, August 5, 2026, at 11:30 a.m. ET to discuss the financial results and related information.PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors.
Kaskela Law Firm Announces Investigation of PACS Group, Inc. (PACS) and Encourages Long-Term PACS Shareholders to Contact the Firm
PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating PACS Group, Inc. (NYSE: PACS) (“PACS”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/case/pacs-group/ Recently a federal securities fraud complaint was filed against PACS on behalf of certain investors who purchased shares of the company's stock between April 11, 2024 and December 16, 2024 (the “Wrongdoing Period”). According to t.
PACS or ALHC: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both PACS Group, Inc. (PACS) and Alignment Healthcare (ALHC). But which of these two stocks presents investors with the better value opportunity right now?
NYSE: PACS ALERT: Investors in shares of PACS Group, Inc. shares should contact the Shareholders Foundation in connection with Lawsuit
SAN DIEGO, July 14, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a lawsuit is currently pending for certain investors in PACS Group, Inc. (NYSE: PACS) shares. NOTICE: Investors who purchased shares of PACS Group, Inc. (NYSE: PACS) prior to April 2024 and continue to hold any of those NYSE: PACS shares have also certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
PACS Group to Acquire Operations of 34 Facilities Across Texas, Montana, New Mexico, North Dakota, South Dakota, and Utah
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) announced today that subsidiaries of the Company have entered into a definitive agreement to acquire the operations of 34 skilled nursing facilities across six western states from Eduro Healthcare (“Eduro”), a family-owned company with a nearly 20-year history of caring for seniors. The operations are in Texas (22 facilities), Montana (six facilities), South Dakota (three facilities), and one facility in each of New Mexico, North Da.
Varist Announces AI-Scale Malware Detection for Healthcare and Medical Imaging
REYKJAVIK, Iceland--(BUSINESS WIRE)--Varist today introduced its DICOM Detection Engine™, a specialized system designed to safeguard healthcare communications networks, electronic health records (EHR) and picture archiving and communication systems (PACS) used in medical imaging from malware, including AI-powered malware that employs artificial intelligence to automate, scale and customize cyberattacks. The Varist malware detection engine combines large-scale file scanning with real-time simula.
Price Targets
Truist Securities Reiterates Buy Rating on PACS Group (PACS)
$62.00
(was $43.00)
David MacDonald
·
Truist Financial
Pacs Group price target raised to $60 from $57 at UBS
$60.00
(was $48.53)
UBS
Pacs Group price target raised to $57 from $50 at UBS
$57.00
(was $45.10)
UBS
Pacs Group price target raised to $52 from $50 at Truist
$52.00
(was $37.96)
Truist Financial
Pacs Group price target raised to $48 from $42 at Oppenheimer
$48.00
(was $41.01)
Michael Wiederhorn
·
Oppenheimer
PACS Group (PACS) PT Raised to $52 as RBC Capital Reiterates Top Pick
$52.00
(was $37.45)
Ben Hendrix
·
RBC Capital
PACS Group (PACS) PT Raised to $47 at RBC Capital
$47.00
(was $36.52)
Ben Hendrix
·
RBC Capital
Pacs Group resumed with a Buy at UBS
$42.00
(was $34.68)
UBS
Pacs Group price target raised to $40 from $32 at Truist
$40.00
(was $33.88)
Truist Financial
Pacs Group price target raised to $33 from $32 at RBC Capital
$33.00
(was $25.31)
RBC Capital
PACS Group (PACS) PT Raised to $44 at Truist Securities
$44.00
(was $38.13)
David MacDonald
·
Truist Financial
Pacs Group price target raised to $40 from $32 at Oppenheimer
$40.00
(was $32.35)
Michael Wiederhorn
·
Oppenheimer
Macquarie Starts PACS Group (PACS) at Outperform
$35.00
(was $30.19)
Tao Qiu
·
Macquarie
Pacs Group price target raised to $32 from $31 at Oppenheimer
$32.00
(was $26.91)
Michael Wiederhorn
·
Oppenheimer
Pacs Group initiated with a Buy at Truist
$32.00
(was $24.81)
David MacDonald
·
Truist Financial
Pacs Group initiated with an Outperform at Oppenheimer
$31.00
(was $24.81)
Michael Wiederhorn
·
Oppenheimer
RBC Capital Starts PACS Group (PACS) at Outperform
$30.00
(was $24.81)
Ben Hendrix
·
RBC Capital